课题基金 / 基金详情

Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells

Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
ACK1(激活的 Cdc42 相关激酶 1)在 T 细胞适配器 SLP-76 信号传导中的作用
批准号:
RGPIN-2017-06461
负责人:
Rudd, Christopher
金额:
$2.48万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Rudd, Christopher的其他基金

相似基金

相关文献

中文摘要
翻译
我们的NSERC研究计划的目标是了解控制下游功能(如钙动员和衔接子和激酶的聚集)的抗原受体近端信号传导事件。介导T细胞活化的初始事件由近端酪氨酸激酶如p56 lck和ZAP-70及其衔接蛋白的磷酸化介导。衔接子反过来介导细胞中整合信号所需的复合物的形成。其中一个关键的衔接蛋白是SLP-76(SH 2 domain containing leukocyte protein of 76 kDa),其在促进T细胞活化和发育中起积极作用。SLP-76含有一个不育-α基序(SAM)结构域,我们以前显示介导SLP-76二聚体和寡聚体的形成。 我们还表明,酪氨酸激酶ACK 1 Cdc 42(细胞分裂周期42)激活的酪氨酸激酶1(ACK 1或Tnk 2)结合到SLP-76和SLP-76 SAM结构域的损失破坏结合。 TCR诱导磷脂酶C(PLCγ1)活化和钙动员的经典模型涉及另一种激酶ZAP-70及其磷酸化和其向SLP-76募集白细胞介素-2诱导型T细胞激酶(ITK)。 我们发现,ACK 1表达诱导SLP-76磷酸化和钙内流,因此,SLP-76-ACK 1模块可以代表T细胞中激活钙动员和F-肌动蛋白组装的第二模块途径。为了测试这个模型,我们提出:目的1:检查SAM结构域介导的寡聚化是否需要ACK 1与SLP-76的结合。 我们已经发现,ACK 1可以磷酸化这些关键酪氨酸上的SLP-76,并通过其SAM结构域与SLP-76结合。 这引入了调节T细胞中SLP-76功能的新机制。 ** 我们建议:目标1:直接评估SLP-76 SAM结构域与ACK 1 SAM结构域的结合,确定SLP-76 SAM结构域中介导ACK 1 SAM结合的特异性位点,评估相互作用是否激活ACK 1并诱导选择性SLP-76酪氨酸残基(Y113,128,145),并定义了TCR相对于辅助受体信号的性质,其有利于SLP-76-ACK 1结合。 目标二:在SLP-76缺陷型J14 Jurkat T细胞和原代T细胞中使用小抑制剂siRNA敲低ACK 1或表达不能与ACK 1结合的SLP-76突变体,以观察其是否降低PLCγ1和ITK磷酸化、催化活性和钙内流,并与SLP-76相关的NCK-WASP协同诱导肌动蛋白聚合。 目的3:评估ACK-1是否与蛋白酪氨酸激酶ZAP-70竞争或补充SLP-76的磷酸化。将比较ACK-1和ZAP-70介导SLP-76和PLCγ1磷酸化以及细胞内钙动员的相对能力。
英文摘要
The goal of our NSERC research program is to understand the antigen-receptor proximal signaling events that control downstream functions such as calcium mobilization and the aggregation of adaptors and kinases. The initial events that mediate activation of T-cells are mediated by proximal tyrosine kinases such as p56lck and ZAP-70 and their phosphorylation of adaptor proteins. Adaptors in turn mediate the formation of complexes needed to integrate signalling in cells. One key adaptor protein is SLP-76 (SH2 domain containing leukocyte protein of 76kDa) which plays a positive role in promoting T cell activation and development. SLP-76 contains a sterile- alpha motif (SAM) domain that we previously showed mediates SLP-76 dimer and oligomer formation. We have also shown that the tyrosine kinase ACK1 Cdc42 (cell division cycle 42)-activated tyrosine kinase 1 (ACK1 or Tnk2) binds to SLP-76 and that the loss of the SLP-76 SAM domain disrupts binding. The classic model for TCR induction of phospholipase C (PLCγ1) activation and calcium mobilization involves another kinase ZAP-70 and its phosphorylation and its recruitment of interleukin-2-inducible T-cell kinase (ITK) to SLP-76. We found that ACK1 expression induced SLP-76 phosphorylation and calcium influx, and as such, the SLP-76-ACK1 module could represent a second modular pathway for the activation calcium mobilization and F-actin assembly in T-cells. To test this model, we propose: Aim 1: to examine whether the SAM domain mediated oligomerization is needed for the binding of ACK1 to SLP-76. We have discovered that ACK1 can phosphorylate SLP-76 on these key tyrosines and binds to SLP-76 via its SAM domain. This introduces are novel mechanism to regulate SLP-76 function in T-cells. ******We propose to: Aim 1: to assess directly SLP-76 SAM domain binding to the ACK1 SAM domain, define specific sites in the SLP-76 SAM domain that mediates ACK1 SAM binding, assess whether the interaction activates ACK1 and induces selective SLP-76 tyrosine residues (Y113,128, 145) and define the nature of TCR vs. co-receptor signals that favours SLP-76-ACK1 binding. Aim 2: to use small inhibitor siRNAs to knock-down ACK1 or express SLP-76 mutants unable to bind to ACK1 in SLP-76 deficient J14 Jurkat T-cells and primary T-cells to see whether it reduces PLCγ1 and ITK phosphorylation, catalytic activity and calcium influx and cooperates with SLP-76 associated NCK-WIP-WASP to induce actin polymerization. Aim 3: to assess whether ACK-1 competes with or complements phosphorylation of SLP-76 by the protein-tyrosine kinase ZAP-70. ACK-1 and ZAP-70 will be compared for their relative abilities to mediate SLP-76 and PLCγ1 phosphorylation as well as the mobilization of intracellular calcium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.95万
  • 财政年份:
    2021
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2020
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2019
  • 负责人:
    Rudd, Christopher
  • 依托单位:
Role of ACK1 (activated Cdc42-associated kinase 1) in adaptor SLP-76 signalling in T-cells
  • 批准号:
    RGPIN-2017-06461
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.48万
  • 财政年份:
    2017
  • 负责人:
    Rudd, Christopher
  • 依托单位:
国内基金
海外基金
选择性ACK1抑制剂的设计、合成及抗肿瘤活性研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    郭靖
  • 依托单位:
ACK1/TNK2在嗜神经肠道病毒感染扩散中的作用机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    54万元
  • 批准年份:
    2022
  • 负责人:
    蒋红兵
  • 依托单位:
Lnc-MPLKIP-6竞争性抑制SIAH1介导的ACK1泛素化调控肺腺癌EGFR-TKI耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    55万元
  • 批准年份:
    2021
  • 负责人:
    马建群
  • 依托单位:
Ack1介导新型EGFR三代抑制剂120067耐药机制研究
  • 批准号:
    81903638
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2019
  • 负责人:
    张弢
  • 依托单位: